Welcome

For thirty years, the attorneys of Wapner, Newman, Wigrizer & Brecher have been committed to protecting the rights of those who have been hurt by another’s mistake or negligence. By focusing on helping people get the justice they deserve for their injuries, we have developed a reputation for outstanding service and results. 

Our firm specializes in assisting those who have been injured by medical negligence, by an unsafe product or prescription drug, in a car accident or while at work.  We also help those who have been the victim of financial mismanagement.

As a premier plaintiffs firm, we do not represent insurance companies, employers or hospitals.

The attorneys of Wapner, Newman, Wigrizer & Brecher bring unsurpassed trial experience to the courtroom, delivering outstanding results.  For their successes, members of our firm have repeatedly been designated “Pennsylvanian Super Lawyers” by their peers.

If you would like to learn more about our firm and whether the lawyers at Wapner, Newman, Wigrizer, & Brecher can help you, please contact us to schedule a free consultation.  

 

Featured Area of Practice

Pharmaceutical Liability

Drug manufacturers, pharmacists and doctors have a responsibility to ensure that the drugs they prescribe their patients do not cause harm. Some drugs have dangerous side effects, while others have the potential to cause long-term damage. These drugs are often the subjects of later recalls. While the Food and Drug Administration (FDA) plays a regulatory role in approving and monitoring drug safety following approval, the manufacturer is ultimately liable for any injuries from their medications.

Wapner Newman has developed a reputation for the handling of pharmaceutical liability claims. Prescription and over-the-counter (OTC) medications are meant to enhance health and bring relief from ailments, but sometimes a drug that is intended to help instead causes injury. Our Drug Liability Department investigates cases involving dangerous drugs such as Propulsid, Baycol, Rezulin, Phenylpropanolamine (PPA), diet drugs (Fen-Phen and Redux), vaccines, Ephedra and Lotronex. These drugs have caused injuries and even death in patients, and many are no longer prescribed to patients or sold OTC.

Read more...

 

  *** GADOLINIUM WARNING ***

Nephrogenic Systemic Fibrosis (NSF) is a medical condition that has come to be associated with exposure to the element gadolinium, when used as a radiocontrast agent during an MRI.

There is strong support in the medical literature of the cause and effect relationship between Gadolinium-based contrast dyes and NSF.  In particular, four of these contrast dyes seem to have been implicated including Omniscan, MultiHance, Magnevist, and OptiMARK

For those afflicted with Nephrogenic Systemic Fibrosis (NSF), the prospect of an NSF lawsuit can seem daunting.  However, it is important to understand that exposure to gadolinium may involve serious negligence, for which one or more parties may be held to account. Therefore, for anyone who has been or has had a loved one afflicted with NSF, it is important to contact our experienced Drug Liability Department. The attorneys at Wapner Newman have developed a reputation for the handling of pharmaceutical liability claims like gadolinium. Click here to contact us for a free consultation today.

 

 

*** DIABETES DRUG WARNING FOR BYETTA ***

The Food and Drug Administration announced that it has received six additional reports of diabetes patients developing a dangerous form of pancreatitis while taking Byetta. Two of the patients died and four are still recovering.

Regulators stressed that patients should stop taking Byetta immediately if they develop signs of acute pancreatitis, a swelling of the pancreas that can cause nausea, vomiting and abdominal pain.

The FDA announcement updated an October alert about 30 reports of Byetta patients developing pancreas problems. At that time Byetta's makers agreed to add information about the reports to the drug's label. Meanwhile, the FDA is seeking a stronger, more prominent warning about the risks. The FDA also advised doctors to consider prescribing other medications to patients with a history of pancreas problems.

More than 700,000 patients with type 2 diabetes have used the injectable drug since it was launched in June 2005.

If you or a loved one have experienced an adverse reaction to Byetta, click here to contact us today for a free consultation. 

 

*** BYETTA UPDATE ***

Following recent reports that Byetta caused the deaths of four diabetes patients, Amylin Pharmaceutical shares took a serious hit. Shares of Amylin Pharmaceuticals, the manufacturer of the diabetes drug, plunged 26 percent, hitting the lowest level in three years for the drug. The stock has lost more than half of its value since last October.

The drop in shares is a direct result of a warning issued by the Food & Drug Administration warning doctors to discontinue use of Byetta. The warning was issued following the death of two Byetta users, both of whom died of complications from pancreatitis, a severe inflammation of the pancreas. In addition to the two confirmed deaths, four more suspected deaths have been reported amongst Byetta users. 

Click here to read an article detailing the drop in shares, and click here if you or a loved one have experienced an adverse reaction to Byetta.

Featured Law News

Vioxx Settlement Payments Begin in August

Merck & Co., the manufacturer of Vioxx, will begin making payments on its $4.85 billion settlement in August. The harmed by Vioxx will receive payments as early as the end of the month. If you or a loved one were harmed by Vioxx, it's not too late to receive the compensation you deserve.
Read more... 

Digitek Recalled Nationwide

Digitek (digoxin tablets), which is used to treat congestive heart failure and atrial fibrillation or atrial flutter (types of fast heartbeats) was recalled nationwide on April 25, 2008 because patients were exposed to a risk of digitalis toxicity. Digitalis toxicity can cause a number of ailments, including severe cardiac impairment and death.
Read more...

Pfizer Begins Settling Painkiller Cases

Pfizer has started settling cases over its Celebrex and Bextra painkillers. More than 3,000 patients have claimed that the drugs caused heart attacks and strokes. Pfizer has reached settlements with law firms representing more than 200 of the thousands who sued over the drugs. Firms have been offered up to $50,000 per client for Bextra cases and as much as $200,000 per client for Celebrex.
Read more... 

FDA Calls for Urgent Warning on Tendon Risks

Federal drug safety officials have imposed the government's most urgent warning on Bayer's AG Cipro and similar antibiotics, citing risks that they can cause tendon ruptures, a serious injury that leaves some patients incapacitated. The FDA ordered makers of flouroquinolone drugs, a potent class of antibiotics, to add a "black box" warning to their products, which include Cipro, Levaquin, Floxin and other medications.
Read more...